Literature DB >> 28153944

Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.

Shuai Yang1, Geoffrey W Abbott2, Wei Dong Gao3, Jin Liu1,4, Chaozhi Luo4, Zhaoyang Hu5.   

Abstract

Remote ischemic conditioning has been convincingly shown to render the myocardium resistant to a subsequent more severe sustained episode of ischemia. Compared with other organs, little is known regarding the effect of transient liver ischemic conditioning. We proposed the existence of cardioprotection induced by remote liver conditioning. Male Sprague-Dawley rats were divided into sham-operated control (no further hepatic intervention) and remote liver ischemic conditioning groups. For liver ischemic conditioning, three cycles of 5 min of liver ischemia-reperfusion stimuli were conducted before-(liver preconditioning), post-myocardial ischemia (liver postconditioning), or in combination of both (liver preconditioning + liver postconditioning). Rats were exposed to 45 min of left anterior descending coronary artery occlusion, followed by 3 h of reperfusion thereafter. ECG and hemodynamics were measured throughout the experiment. The coronary artery was reoccluded at the end of reperfusion for infarct size determination. Blood samples were taken for serum lactate dehydrogenase and creatine kinase-MB test. Heart tissues were taken for apoptosis measurements and Western blotting. Our data demonstrate that liver ischemic preconditioning, postconditioning, or a combination of both, offered strong cardioprotection, as evidenced by reduction in infarct size and cardiac tissue damage, recovery of cardiac function, and inhibition of apoptosis after ischemia-reperfusion. Moreover, liver ischemic conditioning increased cardiac (not hepatic) glycogen synthase kinase-3β (GSK-3β) phosphorylation. Accordingly, inhibition of GSK-3β mimicked the cardioprotective action of liver conditioning. These results demonstrate that remote liver ischemic conditioning protected the heart against ischemia and reperfusion injury via GSK-3β-dependent cell-survival signaling pathway.NEW & NOTEWORTHY Remote ischemic conditioning protects hearts against ischemia and reperfusion (I/R) injury. However, it is unclear whether ischemic conditioning of visceral organs such as the liver, the largest metabolic organ in the body, can produce cardioprotection. This is the first study to show the cardioprotective effect of remote liver ischemic conditioning in a rat model of myocardial I/R injury. We also, for the first time, demonstrated these protective properties are associated with glycogen synthase kinase-3β-dependent cell-survival signaling pathway.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  GSK-3β; cardioprotection; liver ischemic conditioning; myocardial ischemia and reperfusion injury

Mesh:

Substances:

Year:  2017        PMID: 28153944      PMCID: PMC5451530          DOI: 10.1152/japplphysiol.00862.2016

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  35 in total

Review 1.  The renaissance of GSK3.

Authors:  P Cohen; S Frame
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection.

Authors:  Sabzali Javadov; Morris Karmazyn
Journal:  Cell Physiol Biochem       Date:  2007

Review 4.  Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applications.

Authors:  Michael Zaugg; Eliana Lucchinetti; Saeid Behmanesh; Alexander S Clanachan
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat.

Authors:  C Peralta; N Prats; C Xaus; E Gelpí; J Roselló-Catafau
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

6.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

Authors:  Hans Erik Bøtker; Rajesh Kharbanda; Michael R Schmidt; Morten Bøttcher; Anne K Kaltoft; Christian J Terkelsen; Kim Munk; Niels H Andersen; Troels M Hansen; Sven Trautner; Jens Flensted Lassen; Evald Høj Christiansen; Lars R Krusell; Steen D Kristensen; Leif Thuesen; Søren S Nielsen; Michael Rehling; Henrik Toft Sørensen; Andrew N Redington; Torsten T Nielsen
Journal:  Lancet       Date:  2010-02-27       Impact factor: 79.321

7.  Volatile anesthetics protect the ischemic rabbit myocardium from infarction.

Authors:  D K Cope; W K Impastato; M V Cohen; J M Downey
Journal:  Anesthesiology       Date:  1997-03       Impact factor: 7.892

Review 8.  GSK-3beta, a therapeutic target for cardiomyocyte protection.

Authors:  Tetsuji Miura; Takayuki Miki
Journal:  Circ J       Date:  2009-06-09       Impact factor: 2.993

9.  Liver ischemia preconditions the heart against ischemia-reperfusion arrhythmias.

Authors:  Mohammad-Foad Noorbakhsh; Hossein-Ali Arab; Hamid-Reza Kazerani
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

Review 10.  Glycogen synthase kinase 3: a key regulator of cellular fate.

Authors:  J E Forde; T C Dale
Journal:  Cell Mol Life Sci       Date:  2007-08       Impact factor: 9.261

View more
  9 in total

1.  Ischemic limb preconditioning-induced anti-arrhythmic effect in reperfusion-induced myocardial injury: is it mediated by the RISK or SAFE pathway?

Authors:  Xu Cheng; Huan Li; Zhibing Yan; Jin Liu; Zhaoyang Hu
Journal:  Pflugers Arch       Date:  2022-06-13       Impact factor: 4.458

2.  Protective effect of remote liver ischemic postconditioning on pulmonary ischemia and reperfusion injury in diabetic and non-diabetic rats.

Authors:  Dou Huang; Changwei Chen; Yunxia Zuo; Lei Du; Ting Liu; Geoffrey W Abbott; Zhaoyang Hu
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  Remote ischemic preconditioning differentially attenuates post-ischemic cardiac arrhythmia in streptozotocin-induced diabetic versus nondiabetic rats.

Authors:  Zhaoyang Hu; Mou Chen; Ping Zhang; Jin Liu; Geoffrey W Abbott
Journal:  Cardiovasc Diabetol       Date:  2017-04-26       Impact factor: 9.951

4.  Kcne4 deletion sex-specifically predisposes to cardiac arrhythmia via testosterone-dependent impairment of RISK/SAFE pathway induction in aged mice.

Authors:  Zhaoyang Hu; Wei Wei; Leng Zhou; Mou Chen; Geoffrey W Abbott
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

5.  AKT and ERK1/2 activation via remote ischemic preconditioning prevents Kcne2-dependent sudden cardiac death.

Authors:  Zhaoyang Hu; Jin Liu; Leng Zhou; Xin Tian; Geoffrey W Abbott
Journal:  Physiol Rep       Date:  2019-02

6.  Remote liver ischemic preconditioning attenuates myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats.

Authors:  Xinhao Liu; Hui Chen; Zhibing Yan; Lei Du; Dou Huang; Wei Dong Gao; Zhaoyang Hu
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

7.  Impact of Maturation on Myocardial Response to Ischemia and the Effectiveness of Remote Preconditioning in Male Rats.

Authors:  Lucia Kindernay; Veronika Farkasova; Jan Neckar; Jaroslav Hrdlicka; Kirsti Ytrehus; Tanya Ravingerova
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

8.  Analysis of the miRNA-mRNA Regulatory Network Reveals the Biomarker Genes in the Progression of Myocardial Ischemic Reperfusion.

Authors:  Nini Li; Qing Chen
Journal:  J Healthc Eng       Date:  2022-04-13       Impact factor: 3.822

9.  Remote ischemic preconditioning STAT3-dependently ameliorates pulmonary ischemia/reperfusion injury.

Authors:  Nanfu Luo; Jin Liu; Yan Chen; Huan Li; Zhaoyang Hu; Geoffrey W Abbott
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.